DIVA Laboratories, Ltd. (TPEX:4153)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
31.00
0.00 (0.00%)
Jul 21, 2026, 12:42 PM CST
Market Cap1.82B -25.3%
Revenue (ttm)884.63M +4.4%
Net Income90.43M -4.0%
EPS1.54 -3.7%
Shares Out 58.67M
PE Ratio20.13
Forward PEn/a
Dividend2.00 (6.45%)
Ex-Dividend DateJun 12, 2026
Volume7,005
Open31.00
Previous Close31.00
Day's Range31.00 - 31.00
52-Week Range29.00 - 42.35
Beta0.20
Analystsn/a
Price Targetn/a
Earnings DateJul 27, 2026

About DIVA Laboratories

DIVA Laboratories, Ltd. engages in the research, development, manufacture, and sale of medical devices and computer peripherals worldwide. The company provides endo/surgical displays for hybrid and other types of OR applications; color and mono displays for radiology applications; and touch and embedded display, as well as industrial displays. DIVA Laboratories, Ltd. was founded in 1984 and is headquartered in New Taipei City, Taiwan. [Read more]

Sector Healthcare
Founded 1984
Employees 154
Stock Exchange Taipei Exchange
Ticker Symbol 4153
Full Company Profile

Financial Performance

In 2025, DIVA Laboratories's revenue was 868.84 million, an increase of 0.76% compared to the previous year's 862.32 million. Earnings were 90.54 million, a decrease of -3.33%.

Financial Statements